gip/glp-1 ra The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Glucagon-like peptide-1 - Wikipedia

GLP-1s and Obesity Coverage: Differing Perspectives for Employers and Health Plans Posted on August 21, 2025 A Snippet From Our GLP-1 Spotlight Webinar Key Points Employers tend to view obesity as a chronic condition, while health plans lean slightly toward viewing obesity as a lifestyle condition

Consuming adequate protein without exercising the muscles provides the building blocks but not the stimulus

Mitigation strategies that may be employed include: Extended clear liquid diet before surgery Modified anaesthetic techniques Additional monitoring Treating as a 'full stomach' case with appropriate precautions It is essential to discuss your specific medication regimen with your surgical team during pre-operative assessment, ideally several weeks before your procedure

In addition to its glucose-lowering effects, Ozempic also facilitates weight loss by inducing satiety and diminishing appetite, resulting in a decrease in daily calorie intake

Plus, studies suggest that weight loss from GLP-1 medications can lead to lower blood pressure and improved heart health, which is a win-win for your well-being